ClinicalTrials.Veeva

Menu

Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular™ and OMNI Apex ARC™ Stem Compared to Competitive Designs

S

Spokane Joint Replacement Center

Status

Completed

Conditions

Osteoarthritis, Hip

Treatments

Device: OMNI Apex Modular™ Hip Device
Device: OMNI Apex ARC™ Hip Device

Study type

Observational

Funder types

Other

Identifiers

NCT01359540
SJRC-OMNH

Details and patient eligibility

About

This study compares the change in bone density which occurs after hip replacement with different femoral stem devices.

Enrollment

73 patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Minimum age 20 years, maximum age 80 years
  • Osteoarthritis of the hip
  • Elective THA
  • Signed Informed Consent

Exclusion criteria

  • Osteoporosis
  • Revisions
  • Clinically obese (>40 body mass index [BMI])
  • Femoral dysplasia
  • Trochanteric osteotomy
  • Inflammatory arthritis
  • Breast-feeding, pregnancy, or women of childbearing potential without documentation of a negative pregnancy test and not utilizing contraception
  • Patients with a history of having taken or currently taking bisphosphonates, PTH, fluoride therapy or strontium ranelate or patients taking other chronic medications that in the investigator's opinion are known to affect bone mineral density in a substantial way
  • Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study
  • Use of other investigational agent in the last 30 days
  • Unable to sign Informed Consent

Trial design

73 participants in 2 patient groups

APEX Modular
Description:
APEX Modular Stem group
Treatment:
Device: OMNI Apex Modular™ Hip Device
ARC Stem
Description:
ARC Stem group
Treatment:
Device: OMNI Apex ARC™ Hip Device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems